These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30528824)

  • 1. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.
    Witte-Händel E; Wolk K; Tsaousi A; Irmer ML; Mößner R; Shomroni O; Lingner T; Witte K; Kunkel D; Salinas G; Jodl S; Schmidt N; Sterry W; Volk HD; Giamarellos-Bourboulis EJ; Pokrywka A; Döcke WD; Schneider-Burrus S; Sabat R
    J Invest Dermatol; 2019 Jun; 139(6):1294-1305. PubMed ID: 30528824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
    Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
    Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CCL2 with systemic inflammation in Schnitzler syndrome.
    Krause K; Sabat R; Witte-Händel E; Schulze A; Puhl V; Maurer M; Wolk K
    Br J Dermatol; 2019 Apr; 180(4):859-868. PubMed ID: 30339714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
    van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
    Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
    Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F
    Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study.
    Manfredini M; Giuliani AL; Ruina G; Gafà R; Bosi C; Zoppas E; Di Virgilio F; Bettoli V
    Dermatology; 2021; 237(1):111-118. PubMed ID: 31454821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?
    Campbell C; Mayatra JM; Neve AJ; Fletcher JM; Johnston DGW
    Br J Dermatol; 2024 Oct; 191(5):670-679. PubMed ID: 38913409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4.
    Penno CA; Jäger P; Laguerre C; Hasler F; Hofmann A; Gass SK; Wettstein-Ling B; Schaefer DJ; Avrameas A; Raulf F; Wieczorek G; Lehmann JCU; Loesche C; Roth L; Röhn TA
    J Invest Dermatol; 2020 Dec; 140(12):2421-2432.e10. PubMed ID: 32387270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
    Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
    Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 12. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
    Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
    Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
    Wolk K; Brembach TC; Šimaitė D; Bartnik E; Cucinotta S; Pokrywka A; Irmer ML; Triebus J; Witte-Händel E; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Sabat R
    Br J Dermatol; 2021 Jul; 185(1):164-176. PubMed ID: 33400270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
    Sabat R; Šimaitė D; Gudjonsson JE; Brembach TC; Witte K; Krause T; Kokolakis G; Bartnik E; Nikolaou C; Rill N; Coulibaly B; Levin C; Herrmann M; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Wolk K
    J Allergy Clin Immunol; 2023 Apr; 151(4):1015-1026. PubMed ID: 36481267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
    Akdogan N; Dogan S; Incel-Uysal P; Karabulut E; Topcuoglu C; Yalcin B; Atakan N
    Arch Dermatol Res; 2020 May; 312(4):255-262. PubMed ID: 31729595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa.
    Wolk K; Warszawska K; Hoeflich C; Witte E; Schneider-Burrus S; Witte K; Kunz S; Buss A; Roewert HJ; Krause M; Lukowsky A; Volk HD; Sterry W; Sabat R
    J Immunol; 2011 Jan; 186(2):1228-39. PubMed ID: 21148041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.
    Campanati A; Orciani M; Sorgentoni G; Consales V; Offidani A; Di Primio R
    JAMA Dermatol; 2018 Oct; 154(10):1184-1190. PubMed ID: 30140888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.
    Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Albarrán-Planelles C; Rodríguez C; Linares-Barrios M
    Mediators Inflamm; 2017; 2017():2450401. PubMed ID: 28769536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis.
    Kim J; Lee J; Li X; Lee HS; Kim K; Chaparala V; Murphy W; Zhou W; Cao J; Lowes MA; Krueger JG
    J Allergy Clin Immunol; 2023 Sep; 152(3):656-666. PubMed ID: 37271319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.